Gene expression profiling in breast cancer: classification, prognostication, and prediction (Q37958156)

25 August 2017

Gene expression profiling in breast cancer: classification, prognostication, and prediction (English)

1 reference

25 August 2017

1 reference

1

Jorge S Reis-Filho

1 reference

25 August 2017

Lajos Pusztai

2

1 reference

PubMed ID

22098854

25 August 2017

language of work or name

English

0 references

publication date

1 November 2011

1 reference

25 August 2017

1 reference

25 August 2017

378

1 reference

25 August 2017

9805

1 reference

25 August 2017

1812-1823

1 reference

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

25 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Molecular profiling: moving away from tumor philately

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Gene-expression signatures in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Predicting prognosis of breast cancer with gene signatures: are we lost in a sea of data?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

The molecular portraits of breast tumors are conserved across microarray platforms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Supervised risk predictor of breast cancer based on intrinsic subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Identification of molecular apocrine breast tumours by microarray analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Breast cancer molecular profiling with single sample predictors: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Challenges translating breast cancer gene signatures into the clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Gene-expression-based prognostic assays for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Concordance among gene-expression-based predictors for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Use of archived specimens in evaluation of prognostic and predictive biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Genomic grade index is associated with response to chemotherapy in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

High false-negative rate of HER2 quantitative reverse transcription polymerase chain reaction of the Oncotype DX test: an independent quality assurance study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Genomic index of sensitivity to endocrine therapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Stromal gene expression predicts clinical outcome in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Prediction of docetaxel response in human breast cancer by gene expression profiling.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Multifactorial approach to predicting resistance to anthracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Do predictive signatures really predict response to cancer chemotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Genome remodelling in a basal-like breast cancer metastasis and xenograft

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Genomic signatures to guide the use of chemotherapeutics.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Deriving chemosensitivity from cell lines: Forensic bioinformatics and reproducible research in high-throughput biology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Retraction--Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Biological determinants of endocrine resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

International network of cancer genome projects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961539-0

7 January 2021

10.1016/S0140-6736(11)61539-0

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

22098854